Seaport Therapeutics, Inc.
SPTXNasdaqCIK 2042347HealthcareFiscal year ends Dec 31
Reports and events: 9 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0307:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-329537 |
| 2026-08-0307:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-329528 |
| 2026-06-0807:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-260678 |
| 2026-06-0807:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-260671 |
| 2026-05-1119:54 ET | SCHEDULE 13D | Ownership report, active investor | 0000950142-26-001350 |
| 2026-05-0616:26 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-209100 |
| 2026-05-0416:28 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-204086 |
| 2026-04-2706:06 ET | S-1/A | Registration statement, amended | 0001193125-26-178716 |
| 2026-04-1016:01 ET | S-1 | Registration statement | 0001193125-26-151211 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.